Insulin Resistance & Diabetes
Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial
- A. D. Miras; B. Pérez-Pevida; M. Aldhwayan; A. Kamocka; E. R. McGlone; W. Al-Najim; H. Chahal; R. L. Batterham; B. McGowan; O. Khan; V. Greener; A. R. Ahmed; A. Petrie; S. Scholtz; S. R. Bloom; T. M. Tan Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial Lancet Diabetes Endocrinol
Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study
- A. D. Miras; L. L. Chuah; N. Khalil; A. Nicotra; A. Vusirikala; N. Baqai; C. Graham; S. Ravindra; G. Lascaratos; N. Oliver; C. W. le Roux Type 2 diabetes mellitus and microvascular complications 1 year after Roux-en-Y gastric bypass: a case–control study Diabetologia
Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans
- A. D. Miras; R. Herring; A. Vusirikala; F. Shojaee-Moradi; N. C. Jackson; S. Chandaria; S. N. Jackson; A. P. Goldstone; N. Hakim; A. G. Patel; A. M. Umpleby; C. W. Le Roux Measurement of hepatic insulin sensitivity early after the bypass of the proximal small bowel in humans Obes Sci Pract
Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses
- E. R. McGlone; I. Carey; V. Veličković; P. Chana; K. Mahawar; R. L. Batterham; J. Hopkins; P. Walton; R. Kinsman; J. Byrne; S. Somers; D. Kerrigan; V. Menon; C. Borg; A. Ahmed; B. Sgromo; C. Cheruvu; G. Bano; C. Leonard; H. Thom; C. W. le Roux; M. Reddy; Bariatric surgery for patients with type 2 diabetes mellitus requiring insulin: Clinical outcome and cost-effectiveness analyses PLoS Med
Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions?
- W. P. Martin; J. White; F. J. Lopez-Hernandez; N. G. Docherty; C. W. le Roux Metabolic Surgery to Treat Obesity in Diabetic Kidney Disease, Chronic Kidney Disease, and End-Stage Kidney Disease; What Are the Unanswered Questions? Frontiers in endocrinology
Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease
- W. P. Martin; D. Malmodin; A. Pedersen; M. Wallace; L. Fändriks; C. M. Aboud; T. B. Z. Petry; L. P. Cunha da Silveira; A. C. C. da Costa Silva; R. V. Cohen; C. W. le Roux; N. G. Docherty Urinary Metabolomic Changes Accompanying Albuminuria Remission following Gastric Bypass Surgery for Type 2 Diabetic Kidney Disease Metabolites
Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms
- W. P. Martin; N. G. Docherty; C. W. Le Roux Impact of bariatric surgery on cardiovascular and renal complications of diabetes: a focus on clinical outcomes and putative mechanisms Expert review of endocrinology & metabolism
Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease
- W. P. Martin; Y. H. D. Chuah; M. Abdelaal; A. Pedersen; D. Malmodin; S. Abrahamsson; M. Hutter; C. Godson; E. P. Brennan; L. Fändriks; C. W. le Roux; N. G. Docherty Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease Front Endocrinol (Lausanne)